跳至主要内容
临床试验/CTRI/2023/06/054313
CTRI/2023/06/054313已完成4 期

A Prospetive, single arm, open label, single centre clinical study to evaluate the safety and efficacy of Nimson kesh silk plus oil in controlling hairfall and premature greying - NI

Aryanveda Cosmeceuticals0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Subjects aged between 18 to 65 years.
  • Patients having Khalitya (Baldness) and Palitya
  • (premature Greying) as per Ayurvedic classical
  • texts and as per modern parameters i.e., Hair
  • fall, Dandruff and Dryness of hairs have been
  • selected irrespective of any bar of caste, gender, religion and occupation.

排除标准

  • Signs of allergy, irritation or intolerance to the components
  • of the test product
  • Patients who have been diagnosed to have local disease like
  • Alopecia areata, Alopecia totalis, Tinea capitis, Folliculitis
  • devaculans.
  • Patient with hair fall related to any Systemic disorders, any
  • Hormonal disorders, Post CA treatments and Vitiligo.
  • Pregnancy or lactation.
  • Participation in other clinical trials.
  • Unwilling/unable to sign the informed consent.

研究者

发起方
Aryanveda Cosmeceuticals

相似试验